2月14日，美因基因(06667)盘中下跌5.54%，截至14:06，报8.01元/股，成交113.44万元。
美因基因有限公司是中国领先的基因检测平台公司，专注于提供消费级基因检测和癌症筛查服务，自2016年成立以来已进行超过1900万次基因检测。公司提供多种基因检测服务，其高通量检测平台每日可处理50000个样本，并在全国340多个城市的1800多个医疗保健机构以及多家电商和在线健康护理平台提供服务。
截至2024年中报，美因基因营业总收入1.07亿元、净利润3696.9万元。
2月13日，公司以每股7.96-8.2港元回购1400.00股,回购金额1.139万港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.